KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.03 $5.34 Friday, 26th Apr 2024 BCRX stock ended at $4.16. During the day the stock fluctuated 3.40% from a day low at $4.12 to a day high of $4.26.
90 days $4.03 $6.35
52 weeks $4.03 $9.07

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
Jul 17, 2020 $5.02 $5.15 $4.98 $5.04 6 047 400
Jul 16, 2020 $5.06 $5.15 $5.00 $5.03 3 992 900
Jul 15, 2020 $5.24 $5.36 $5.00 $5.22 5 009 800
Jul 14, 2020 $4.97 $5.24 $4.76 $5.23 8 405 400
Jul 13, 2020 $5.42 $5.45 $4.94 $4.95 8 012 100
Jul 10, 2020 $5.55 $5.60 $5.24 $5.44 5 581 800
Jul 09, 2020 $5.58 $5.82 $5.41 $5.52 9 555 600
Jul 08, 2020 $5.86 $6.03 $5.19 $5.43 14 698 300
Jul 07, 2020 $4.96 $5.56 $4.92 $5.41 10 548 900
Jul 06, 2020 $5.12 $5.13 $4.88 $4.95 5 355 700
Jul 02, 2020 $4.95 $5.07 $4.76 $5.02 6 108 958
Jul 01, 2020 $4.70 $4.92 $4.59 $4.91 5 395 760
Jun 30, 2020 $4.90 $4.91 $4.56 $4.77 8 425 852
Jun 29, 2020 $5.17 $5.29 $4.85 $4.98 12 943 824
Jun 26, 2020 $4.41 $4.90 $4.38 $4.83 16 651 406
Jun 25, 2020 $4.21 $4.32 $4.12 $4.30 3 789 029
Jun 24, 2020 $4.23 $4.33 $4.06 $4.22 5 171 920
Jun 23, 2020 $4.10 $4.32 $4.10 $4.27 7 037 832
Jun 22, 2020 $3.98 $4.13 $3.84 $4.12 7 350 295
Jun 19, 2020 $4.13 $4.19 $3.89 $3.89 20 151 345
Jun 18, 2020 $4.08 $4.21 $3.91 $4.11 5 630 431
Jun 17, 2020 $4.36 $4.36 $4.09 $4.09 5 953 743
Jun 16, 2020 $4.57 $4.61 $4.27 $4.37 6 232 657
Jun 15, 2020 $4.21 $4.68 $4.13 $4.49 6 545 850
Jun 12, 2020 $4.37 $4.37 $4.08 $4.29 5 796 238
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT